Press release
Cancer Gene Therapy Market Report Provides Insights Into Market Evolution And Growth Prospects
Cancer Gene Therapy Market
Projected Market Growth for Cancer Gene Therapy by 2030
The cancer gene therapy market is poised for substantial expansion over the next several years. Analysts predict the market will reach $8.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 16.1%. This surge is fueled by a rising demand for personalized cancer treatments and increased investments in the manufacturing infrastructure of cell and gene therapies. Additional growth drivers include the advancement of next-generation viral vectors, an increased focus on combination oncology treatments, and the growing adoption of precision oncology strategies. Key emerging trends during the forecast period feature the development of targeted gene therapy platforms, wider uptake of CAR-T and TCR therapies, efforts to optimize viral vectors, expansion of personalized cancer gene treatments, and the integration of biomarker-driven therapy selection.
The cancer gene therapy market size has grown rapidly in recent years. It will grow from $4.21 billion in 2025 to $4.9 billion in 2026 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advancements in molecular oncology research, expansion of clinical trials in gene therapy, increasing investment in biopharmaceutical R&D, regulatory approvals of early gene therapies, improved vector manufacturing capabilities.
Download a free sample of the cancer gene therapy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27233&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Players Leading the Cancer Gene Therapy Market
A number of prominent companies are shaping the landscape of the cancer gene therapy industry. Some of the major players include Bristol Myers Company, Novartis AG, GSK plc., Gilead Sciences Inc., Amgen Inc., Orchard Therapeutics Plc, AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, Abeona Therapeutics Inc., Kite Pharma Inc., Janssen Biotech Inc., Mustang Bio Inc., Intellia Therapeutics Inc., CRISPR Therapeutics AG, and Caribou Biosciences Inc.
Strategic Acquisitions Enhancing Market Capabilities
In a notable move in May 2025, UK-based biopharmaceutical firm AstraZeneca plc acquired EsoBiotec B.V., a Swiss biotechnology company specializing in cancer gene therapies, for an undisclosed sum. This acquisition supports AstraZeneca's strategic goal to bolster its cell therapy portfolio and accelerate the development of next-generation oncology and immune-mediated disease treatments, positioning the company to better compete in this fast-growing market.
View the full cancer gene therapy market report:
https://www.thebusinessresearchcompany.com/report/cancer-gene-therapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Innovative Trends Driving Advances in Cancer Gene Therapy
Leading companies in this sector are prioritizing the development of sophisticated therapies like CAR-T cell treatments to improve precision, boost patient outcomes, and effectively target cancer cells while minimizing harm to healthy tissues. CAR-T therapy involves genetically engineering a patient's immune cells by adding special receptors that enhance their ability to detect and eliminate cancer cells.
For example, in April 2024, ImmunoACT, a biotechnology company based in India, introduced NexCAR19 (actalycabtagene autoleucel), the country's first domestically developed CAR-T cell therapy targeting B-cell lymphomas and leukemias. This therapy reprograms a patient's own T cells to recognize and destroy cancer cells, utilizing advanced chimeric antigen receptor technology. The local manufacturing of NexCAR19 makes it a more affordable and accessible option compared to imported therapies, marking a significant milestone in India's growing participation in the global cancer gene therapy market and highlighting progress in personalized cancer treatment innovation.
Core Segments Defining the Global Cancer Gene Therapy Market
The global cancer gene therapy market is categorized into several key segments to better understand its structure and applications:
1) Therapy Types:
- Gene Induced Immunotherapy
- Oncolytic Virotherapy
- Gene Transfer
2) Disease Indications:
- Large B-Cell Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia (ALL)
- Melanoma (lesions)
- Other Indications
3) Vector Types:
- Lentivirus
- RetroVirus And Gamma RetroVirus
- Adeno-Associated Virus (AAV)
- Modified Herpes Simplex Virus
- Adenovirus
- Other Vector Types
4) End Users:
- Hospitals
- Research Institutes
- Biopharmaceutical Companies
- Cell Therapy Manufacturing Centers
- Other End Users
Further sub-segmentation includes:
- Within Gene Induced Immunotherapy: CAR-T Cell Therapy, TCR (T-Cell Receptor) Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell-Based Gene Therapy, NK Cell Gene Therapy
- Within Oncolytic Virotherapy: Adenoviruses, Herpes Simplex Virus (HSV), Reovirus, Vaccinia Virus, Newcastle Disease Virus (NDV)
- Within Gene Transfer: Viral Gene Transfer, Non-Viral Gene Transfer
These detailed categories help illustrate the diversity and complexity of the cancer gene therapy market, reflecting its multi-faceted approach to combating cancer through genetic and cellular techniques.
Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Gene Therapy Market Report Provides Insights Into Market Evolution And Growth Prospects here
News-ID: 4603950 • Views: …
More Releases from The Business Research Company
Cancer Treatment Facilities Market Study Explores Industry Growth Toward $70.52 …
The cancer treatment facilities market is on track for significant growth over the coming years, driven by advances in medical technology and expanding care options. With a focus on personalized therapies and integrated treatment approaches, the sector is evolving rapidly to meet increasing patient needs. Let's explore how this market is progressing, the key players involved, and the major trends shaping its future.
Projected Expansion of the Cancer Treatment Facilities Market…
Cancer In Vitro Diagnostics (IVD) Market Research Reveals Path To $19.85 Billion …
The cancer in vitro diagnostics (IVD) market is on track for significant expansion over the coming years. Advancements in technology and a growing focus on personalized medicine are driving this sector toward substantial growth, with promising innovations enhancing cancer detection and treatment.
Projected Market Size and Growth of the Cancer In Vitro Diagnostics IVD Market
The cancer in vitro diagnostics (IVD) market is expected to reach $19.85 billion by 2030,…
Cancer Cachexia Market Demonstrates Long-Term Growth Potential At 5.1% CAGR
The cancer cachexia market is on track for significant expansion over the coming years, driven by advancements in treatment approaches and increased focus on patient quality of life. This growing segment of oncology care is attracting attention from pharmaceutical companies and researchers eager to develop more effective therapies for this complex metabolic syndrome. Let's explore the current market size, key players, emerging trends, and segment details shaping the future of…
Calciphylaxis Treatment Market Outlook Signals Expansion To $3.02 Billion Throug …
The calciphylaxis treatment market is on course for notable expansion in the coming years, driven by advancements in medical therapies and a growing commitment to improving patient outcomes. As new treatment methods emerge and healthcare approaches evolve, this sector is poised for significant development and innovation.
Projected Market Size and Growth Path for the Calciphylaxis Treatment Market
The calciphylaxis treatment market is anticipated to expand to $3.03 billion by 2030,…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
